Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Gene Products, env (compound)
Most Correlated Studies
- B cells activated with anti-IgM and CpG DNA then treated with high affinity HIV gp120 protein R66M
- Acute monocytic leukemia (AML) THP-1 cells HIV gp120 or LPS stimulated following SB203580 treatment
- PBMCs of donors immunized with RV144 (ALVAC-gp120) HIV vaccine showing high or low ADCP
- Neuronal damage by HIV glycoprotein 120 expression in CCR5 KO and wildtype mice
- Human plasmocytoid dendritic cells treated with HIV-1 matrix protein p17 or CpG
Most Relevant Literature
- Targeting the HIV-1 Env fusion protein.
- Stoichiometry for entry and binding properties of the Env protein of R5 T cell-tropic HIV-1 and its …
- Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, …
- Expression profiles of human endogenous retrovirus (HERV)-K and HERV-R Env proteins in various cance…
- In silico discovery of epitopes of gag and env proteins for the development of a multi-epitope vacci…
Most Relevant Clinical Trials
- A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted E…
- Dose Escalation Trial of CD40.HIVRI.Env Vaccine Combined or Not With a DNA-HIV-PT123 HIV-1 Vaccine i…
- A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tu…
- A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunog…
- A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine R…
